![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Alarcon-Segovia D, Perez-Vazquez M E, Villa A R, Drenkard C, Cabiedes J. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Seminars in Arthritis and Rheumatism 1992; 21: 275–286
- Branch D W, Silver R M, Blackwell J L, Reading J C, Scott J R. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstetrics and Gynecology 1992; 80: 614–620
- Carreras L O, Defreyn G, Machin S J, Vermylen J, Deman R, Spitz B, et al. Arterial thrombosis, intrauterine death and ‘lupus’ anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981; 1: 244–246
- Cowchock F S, Reece E A, Balaban D, Branch D W, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. American Journal of Obstetrics and Gynecology 1992; 166: 1318–1323
- Kutteh W H, Ermel L D. A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin. American Journal of Reproductive Immunology 1996; 35: 402–407
- Landy H J, Kessler C, Kelly W K, Weingold A B. Obstetrics performance in patients with the lupus anticoagulant and/or anticardiolipin antibodies. American Journal of Perinatology 1992; 9: 146–151
- Lockshin M D, Erkan D. Treatment of antiphospholipid syndrome. New England Journal of Medicine 2003; 349: 1177–1179
- Lockwood C J, Reece E A, Romero R, Hobbins J C. Antiphospholipid antibodies and pregnancy wastage. Lancet 1986; 2: 742–743
- Out H J, Kooijman C D, Bruinse H W, Derksen R H. Histopathological findings in placentae from patients with intrauterine death and antiphospholipid antibodies. European Journal of Obstetrics, Gynaecology and Reproductive Biology 1991; 41: 179–186
- Plouffe L, Jr, White E W, Tho S P, Sweet C S, Layman L C, Whitman G F, et al. Etiologic factors of recurrent abortion and subsequent reproductive performance of couples: have we made any progress in the past 10 years?. American Journal of Obstetrics and Gynecology 1992; 167: 313–201
- Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). British Medical Journal 1997; 314: 253–257
- Rai R S, Clifford K, Cohen H, Regan L. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Human Reproduction 1995; 10: 3301–3304
- Rote N S, Walter A, Lyden T W. Antiphospholipid antibodies – lobsters or red herrings?. American Journal of Reproductive Immunology 1992; 28: 31–37
- Taylor P V, Skerrow S M, Redman C W. Pre-eclampsia and antiphospholipid antibody. British Journal of Obstetrics and Gynaecology 1991; 98: 604–606
- Tomer Y, Viegas O A, Swissa M, Koh S C, Shoenfeld Y. Levels of lupus auto antibodies in pregnant SLE patients: correlation with disease activity and pregnancy outcome. Clinical and Experimental Rheumatology 1996; 14: 275–280
- Warburton D. Reproductive loss: how much is preventable?. New England Journal of Medicine 1987; 316: 158–160
- Wilcox A J, Weinberg C R, O'Connor J F, Braid D D, Schlatterer J P, Canfield R E, et al. Incidence of early loss of pregnancy. New England Journal of Medicine 1988; 319: 189–194
- Wilson W A, Gharavi A E, Koike T, Lockshin M D, Branch D W, Piette J C, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis and Rheumatism 1999; 42: 1309–1311